Wrendon Timothy - Feb 14, 2025 Form 4 Insider Report for OXBRIDGE RE HOLDINGS Ltd (OXBR)

Role
CFO & Secretary, Director
Signature
/s/ Wrendon Timothy
Stock symbol
OXBR
Transactions as of
Feb 14, 2025
Transactions value $
-$3
Form type
4
Date filed
2/20/2025, 04:04 PM
Previous filing
Apr 17, 2024
Next filing
Sep 30, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OXBR Ordinary Shares Award $0 +25K +33.31% $0.00 100K Feb 14, 2025 Direct F1
transaction OXBR Ordinary Shares Options Exercise $180K +90K +89.96% $2.00 190K Feb 14, 2025 Direct F2
transaction OXBR Ordinary Shares Tax liability -$180K -35K -18.43% $5.14 155K Feb 14, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OXBR Share Options (right to buy) Options Exercise $0 -90K -100% $0.00 0 Feb 14, 2025 Ordinary Shares 90K $2.00 Direct F2
holding OXBR Share Options (right to buy) 75K Feb 14, 2025 Ordinary Shares 75K $6.00 Direct F3
holding OXBR Share Options (right to buy) 10K Feb 14, 2025 Ordinary Shares 10K $6.06 Direct F3
holding OXBR Share Options (right to buy) 10K Feb 14, 2025 Ordinary Shares 10K $6.00 Direct F3
holding OXBR Warrants to Purchase Ordinary Shares 7.5K Feb 14, 2025 Ordinary Shares 7.5K $7.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted ordinary shares under the Issuer's 2021 Omnibus Incentive Plan.
F2 Represents a "net exercise" of 90,000 outstanding share options. 35,020 shares were withheld by the company for payment of the exercise price at a share price of $5.14. The remaining net 54,980 ordinary shares were issued to, and retained by, the reporting person.
F3 These share options are currently exercisable and vested in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st and January 1st of each calendar year, over a four-year period.
F4 Currently exercisable.